Home / Clinical Laboratory / Clinical Analyzer Calibrators and Reagents / Reagents / Reagent / Reagent Immulite® Tumor Marker Assay OM-MA CA 125 For Immulite® / Immulite® 1000 Systems 100 Tests10380969
Picture of Reagent Immulite® Tumor Marker Assay OM-MA CA 125 For Immulite® / Immulite® 1000 Systems 100 Tests10380969

Reagent Immulite® Tumor Marker Assay OM-MA CA 125 For Immulite® / Immulite® 1000 Systems 100 Tests10380969

Reagent-Immulite®-Tumor-Marker-Assay-OM-MA-CA-125-For-Immulite®--Immulite®-1000-Systems-100-Tests10380969

SKU #

#914049

MPN #

10380969

Brand

Siemens

Stock

In Stock

Quantity

100

Features

OM-MA CA-125 RGT 100/BX IMMULITE 1000 SMHCDG

$196.68 USD

Product Specifications Product Usage Additional Information
Print
Attribute Name Attribute Value
McKesson # 914049
Manufacturer # 10380969
Brand Immulite®
Manufacturer Siemens
Application Reagent
For Use With For Immulite® / Immulite® 1000 Systems
Form Liquid
Number of Tests 100 Tests
Sample Type Serum Sample
Storage Requirements Requires Refrigeration
Test Name OM-MA CA 125
Test Type Tumor Marker Assay
Type Solid-phase Two-site Chemiluminescent Immunometric Assay
UNSPSC Code 41116010
Compare Selected Items Email

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • For the quantitative measurement of CA125 antigen in serum, as an aid in monitoring the response to therapy for patients with epithelian ovarian cancer, and in detecting residual ovarian cancer in patients who have undergone first-line therapy and would be considered for diagnostic second-look procedures
  • Incubation Cycles: 2 × 30 minutes